Curaleaf Holdings (CURLF) Total Debt (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Total Debt of $512.9 million for Q4 2025, up 9.08% year-on-year from $470.2 million in Q4 2024, and up 9.08% on a QoQ basis from $470.2 million in Q4 2024.
Curaleaf Holdings (CURLF) Total Debt (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Total Debt for 7 consecutive years, with $512.9 million the latest figure, recorded in Q4 2025.
- Quarterly Total Debt rose 9.08% year-over-year to $512.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $512.9 million (up 9.08% YoY) and the FY2025 annual result came in at $512.9 million, up 9.08% from the prior year.
- Total Debt grew to $512.9 million in Q4 2025 per CURLF's latest filing, from $470.2 million in the prior quarter.
- Over the last five years, Total Debt for CURLF reached as high as $610.8 billion in Q1 2022 and fell as low as $339.5 million in Q1 2021.
- A 5-year average of $41.2 billion and a median of $512.9 million in 2025 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2022 — Total Debt surged 179799.44% — and 2024, when it fell 20.09%.
- Year by year, Total Debt stood at $467.1 million in 2021, then increased by 26.17% to $589.3 million in 2022, then fell by 4.94% to $560.2 million in 2023, then declined by 16.06% to $470.2 million in 2024, then increased by 9.08% to $512.9 million in 2025.
- According to Business Quant data, Total Debt over the past three periods registered $512.9 million, $470.2 million, and $467.2 million for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 512.92 Mn |
| Dec 31, 2024 | 470.21 Mn |
| Sep 30, 2024 | 467.19 Mn |
| Jun 30, 2024 | 469.98 Mn |
| Dec 31, 2023 | 560.19 Mn |
| Sep 30, 2023 | 584.62 Mn |
| Jun 30, 2023 | 574.07 Mn |
| Dec 31, 2022 | 589.33 Mn |
| Sep 30, 2022 | 620.66 Mn |
| Jun 30, 2022 | 605.91 Mn |
| Mar 31, 2022 | 610.78 Bn |
| Dec 31, 2021 | 467.07 Mn |
| Sep 30, 2021 | 349.41 Mn |
| Jun 30, 2021 | 345.61 Mn |
| Mar 31, 2021 | 339.51 Mn |
| Dec 31, 2020 | 291.50 Mn |
| Sep 30, 2020 | 283.40 Mn |
| Dec 31, 2019 | 104.95 Mn |